Jump to section
To label data at scale to enable breakthroughs in medical AI.
The market for AI development, particularly in healthcare, is rapidly evolving as organizations seek to harness the power of data for improved outcomes. And, with the increasing complexity of data types, there is a growing need for high-quality data annotation.
This is where Centaur Labs comes in, with its platform that allows health and science organizations to accelerate AI development through accurate multimodal data labeling for training, evaluation and feedback. By incorporating competitive elements into the annotation process via its mobile app DiagnosUs, Centaur Labs ensures skilled annotators deliver high-quality results.
In addition, the company recently launched an on-demand AI data labeling product that allows developers to collect labels from experts in under an hour, significantly enhancing efficiency. These innovations position the company for an exciting future as a leader in the healthcare AI space.
Kirsty
Company Specialist at Welcome to the Jungle
Aug 2021
$15m
SERIES A
Jun 2019
$4m
SEED
This company has top investors
Erik Duhaime
(Co-Founder & CEO)Graduated from the Massachusetts Institute of Technology with a PhD in Management. Co-founded Centaur Labs in 2017 and has served as the CEO since.
Tom Gellatly
(Co-Founder & VP of Engineering)Graduated from the University of Michigan with a Bachelor of Engineering. Previously worked at Cruise Automation as a Software Engineer and Engineering Manager, at General Motors as an Engineering Group Manager and at Sidecar as the Director of Mobile Engineering.
Zach Rausnitz
(Co-Founder & CTO)Previously an Interactive News Developer at the Washington City Paper and a Reporter and Editor at FierceMarkets.